Evidence map›Paper›PMID 41923005›Full record

ArticleBMC medical imaging2026

Evaluating the predictive value of dynamic contrast-enhanced MRI and six diffusion models for prognostic factors in mass-type invasive ductal carcinoma of the breast.

Lijia Wang, Cece Dong, Haiyun Wang, Li Yang, Chen Zhang, Mengzhu Wang, Qi Wang, Qian Xu

Abstract read
In one paragraph

Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lijia Wang *Department of CT & MRI, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Cece Dong *Department of Medical Imaging, Cangzhou Central Hospital, Cangzhou, Hebei, China.
Haiyun WangDepartment of CT & MRI, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Li YangDepartment of CT & MRI, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Chen ZhangMR Research Collaboration, Siemens Healthineers Ltd., Beijing, China.
Mengzhu WangMR Research Collaboration, Siemens Healthineers Ltd., Beijing, China.
Qi WangDepartment of CT & MRI, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. ja1109w@hebmu.edu.cn.
Qian XuDepartment of CT & MRI, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. xuqian@hebmu.edu.cn.

Funding

2024 Government-Funded Clinical Medicine Outstanding Talents Training Program ZF2024116the Medical Science Research Project of Hebei 20221336
6 · The paper itself

Abstract

backgroundAccurate prognostic stratification of invasive ductal carcinoma (IDC) of breast is essential for personalized breast cancer treatment, but single-index DWI fails to capture the complex non-Gaussian diffusion of intratumoral water molecules. This study aims to evaluate the diagnostic efficacy of combining dynamic enhanced magnetic resonance imaging (DCE-MRI) features and quantitative parameters from six diffusion models in predicting prognostic factors of mass-type breast invasive ductal carcinoma (IDC).

methods100 patients with mass-type IDC who underwent routine breast MRI and multi-b-value DWI examinations in our hospital were enrolled. All patients were confirmed pathologically and had immunohistochemical results for Ki-67 and tumor-infiltrating lymphocytes (TILs). Among them, 15 cases exhibited low Ki-67 expression, while 85 cases showed high Ki-67 expression; 54 cases were categorized in the low TILs group, and 46 cases were classified in the medium-high TILs group. Clinical features, routine MRI features, and parameters from six diffusion models, including continuous-time random walk (CTRW), fractional order calculus (FROC), stretched exponential model (SEM), intravoxel incoherent motion magnetic resonance imaging (IVIM), and diffusion kurtosis imaging (DKI), were recorded. Independent predictive factors were identified through multivariate regression analysis. Receiver operating characteristic (ROC) curves were constructed to evaluate and compare the diagnostic efficacy of both independent and combined parameters. The Delong test was used to compare the diagnostic efficacy of each model.

resultsMultivariate logistic regression analysis identified αCTRW as an independent predictor of Ki-67 and TILs levels, with AUCs of 0.732 and 0.649, respectively. Additionally, the combination of time signal curve (TIC) and αCTRW for predicting TILs levels yielded an AUC of 0.700. There was no statistically significant difference between the AUCs of αCTRW and the combined diagnostic model (αCTRW + TIC).

conclusionCTRW-α is a promising non-invasive imaging biomarker for predicting Ki-67 and TILs levels in mass-type IDC. By capturing intratumoral water molecule diffusion heterogeneity, it supports accurate preoperative prognostic stratification and personalized treatment decision-making, highlighting the value of multi-exponential DWI models in breast cancer imaging.

trial registrationNot applicable.

Indexed as

Breast NeoplasmsCarcinoma, Ductal, BreastDiffusion Magnetic Resonance ImagingAdultAgedDynamic Contrast Enhanced Magnetic Resonance ImagingFemaleHumansKi-67 AntigenMiddle AgedPredictive Value of TestsPrognosisKi-67 AntigenBreast cancerDiffusion-weighted imagingDynamic contrast-enhanced MRIPrognostic factors

Identifiers

PMID41923005
PMCPMC13169615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.